{"id":"https://openalex.org/W2059980332","doi":"https://doi.org/10.1159/000088297","title":"Characterization of Prognostic Factors and Efficacy in a Phase-II Study with Docetaxel and Estramustine for Advanced Hormone Refractory Prostate Cancer","display_name":"Characterization of Prognostic Factors and Efficacy in a Phase-II Study with Docetaxel and Estramustine for Advanced Hormone Refractory Prostate Cancer","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W2059980332","doi":"https://doi.org/10.1159/000088297","mag":"2059980332","pmid":"https://pubmed.ncbi.nlm.nih.gov/16249643"},"language":"en","primary_location":{"id":"doi:10.1159/000088297","doi":"https://doi.org/10.1159/000088297","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000088297","pdf_url":null,"source":{"id":"https://openalex.org/S2769437601","display_name":"Oncology Research and Treatment","issn_l":"2296-5262","issn":["2296-5262","2296-5270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Research and Treatment","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066792434","display_name":"Thomas Nelius","orcid":"https://orcid.org/0000-0001-8858-5602","observed_orcids":["https://orcid.org/0000-0001-8858-5602"]},"institutions":[{"id":"https://openalex.org/I95793202","display_name":"Otto-von-Guericke-Universit\u00e4t Magdeburg","ror":"https://ror.org/00ggpsq73","country_code":"DE","type":"education","lineage":["https://openalex.org/I95793202"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Thomas Nelius","raw_affiliation_strings":["Department of Urology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany. thomas.nelius@medizin.uni-magdeburg.de","Department of Urology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany. thomas.nelius@medizin.uni-magdeburg.de","institution_ids":["https://openalex.org/I95793202"]},{"raw_affiliation_string":"Department of Urology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany","institution_ids":["https://openalex.org/I95793202"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109990956","display_name":"F. Reiher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I95793202","display_name":"Otto-von-Guericke-Universit\u00e4t Magdeburg","ror":"https://ror.org/00ggpsq73","country_code":"DE","type":"education","lineage":["https://openalex.org/I95793202"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Frank Reiher","raw_affiliation_strings":["Department of Urology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany","institution_ids":["https://openalex.org/I95793202"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073993226","display_name":"Tobias Lindenmeir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I95793202","display_name":"Otto-von-Guericke-Universit\u00e4t Magdeburg","ror":"https://ror.org/00ggpsq73","country_code":"DE","type":"education","lineage":["https://openalex.org/I95793202"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Tobias Lindenmeir","raw_affiliation_strings":["Department of Urology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany","institution_ids":["https://openalex.org/I95793202"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023716783","display_name":"Tobias Klatte","orcid":"https://orcid.org/0000-0002-4392-6861","observed_orcids":["https://orcid.org/0000-0002-4392-6861"]},"institutions":[{"id":"https://openalex.org/I95793202","display_name":"Otto-von-Guericke-Universit\u00e4t Magdeburg","ror":"https://ror.org/00ggpsq73","country_code":"DE","type":"education","lineage":["https://openalex.org/I95793202"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Tobias Klatte","raw_affiliation_strings":["Department of Urology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany","institution_ids":["https://openalex.org/I95793202"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075245333","display_name":"O. Rau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I95793202","display_name":"Otto-von-Guericke-Universit\u00e4t Magdeburg","ror":"https://ror.org/00ggpsq73","country_code":"DE","type":"education","lineage":["https://openalex.org/I95793202"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Olrik Rau","raw_affiliation_strings":["Department of Urology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany","institution_ids":["https://openalex.org/I95793202"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026961045","display_name":"Jens Burandt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I95793202","display_name":"Otto-von-Guericke-Universit\u00e4t Magdeburg","ror":"https://ror.org/00ggpsq73","country_code":"DE","type":"education","lineage":["https://openalex.org/I95793202"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jens Burandt","raw_affiliation_strings":["Department of Urology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany","institution_ids":["https://openalex.org/I95793202"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002277031","display_name":"St\u00e9phanie Filleur","orcid":"https://orcid.org/0000-0002-3420-5536","observed_orcids":["https://orcid.org/0000-0002-3420-5536"]},"institutions":[{"id":"https://openalex.org/I95793202","display_name":"Otto-von-Guericke-Universit\u00e4t Magdeburg","ror":"https://ror.org/00ggpsq73","country_code":"DE","type":"education","lineage":["https://openalex.org/I95793202"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Stephanie Filleur","raw_affiliation_strings":["Department of Urology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany","institution_ids":["https://openalex.org/I95793202"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108383017","display_name":"Ernst Peter Allhoff","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ernst Peter Allhoff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5328,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.73730901,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"28","issue":"11","first_page":"573","last_page":"578"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.925000011920929},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.968999981880188},{"id":"https://openalex.org/keywords/estramustine","display_name":"estramustine","score":1.0},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.9440000057220459},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9739999771118164},{"id":"https://openalex.org/keywords/psa-response","display_name":"PSA response","score":0.7950000166893005},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.8399999737739563},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8360000252723694},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8330000042915344},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.7540000081062317},{"id":"https://openalex.org/keywords/baseline-hemoglobin","display_name":"baseline hemoglobin","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.9788596630096436},{"id":"https://openalex.org/C2780201970","wikidata":"https://www.wikidata.org/wiki/Q412939","display_name":"Estramustine","level":5,"score":0.9265943765640259},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8367767333984375},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6335344910621643},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6035934686660767},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6034554243087769},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.588929295539856},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5292512774467468},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5070075988769531},{"id":"https://openalex.org/C2781406297","wikidata":"https://www.wikidata.org/wiki/Q409450","display_name":"Prostate-specific antigen","level":4,"score":0.49618062376976013},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42764413356781006},{"id":"https://openalex.org/C2994223898","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate disease","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004961","descriptor_name":"Estramustine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004961","descriptor_name":"Estramustine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005858","descriptor_name":"Germany","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017430","descriptor_name":"Prostate-Specific Antigen","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1159/000088297","doi":"https://doi.org/10.1159/000088297","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000088297","pdf_url":null,"source":{"id":"https://openalex.org/S2769437601","display_name":"Oncology Research and Treatment","issn_l":"2296-5262","issn":["2296-5262","2296-5270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Research and Treatment","raw_type":"journal-article"},{"id":"pmid:16249643","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16249643","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Onkologie","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W542822","https://openalex.org/W79536663","https://openalex.org/W1571487648","https://openalex.org/W1816774827","https://openalex.org/W1853704205","https://openalex.org/W1879747226","https://openalex.org/W1979300931","https://openalex.org/W1984749582","https://openalex.org/W2003985632","https://openalex.org/W2014145760","https://openalex.org/W2014936680","https://openalex.org/W2027740621","https://openalex.org/W2043368900","https://openalex.org/W2058680827","https://openalex.org/W2058917998","https://openalex.org/W2064536538","https://openalex.org/W2080419003","https://openalex.org/W2080439368","https://openalex.org/W2081060593","https://openalex.org/W2092116062","https://openalex.org/W2097120102","https://openalex.org/W2118873545","https://openalex.org/W2120292596","https://openalex.org/W2120466617","https://openalex.org/W2129407316","https://openalex.org/W2129683520","https://openalex.org/W2139984188","https://openalex.org/W2153140330","https://openalex.org/W2155679349","https://openalex.org/W2155839539","https://openalex.org/W2184174775","https://openalex.org/W2991939077","https://openalex.org/W4293241248"],"related_works":["https://openalex.org/W2145300558","https://openalex.org/W2123127226","https://openalex.org/W2082245048","https://openalex.org/W2048141323","https://openalex.org/W2264938055","https://openalex.org/W2131039431","https://openalex.org/W2278266168","https://openalex.org/W1992266822","https://openalex.org/W432702446","https://openalex.org/W1886024937"],"abstract_inverted_index":{"BACKGROUND:":[0],"Docetaxel":[1],"based":[2],"chemotherapy":[3],"not":[4],"only":[5],"reduces":[6],"pain":[7],"and":[8,31,39,60,89,121,128,166,174,208],"improves":[9,23],"quality":[10],"of":[11,29,111,147,172],"life":[12],"in":[13,33,137,143,179,214],"advanced":[14],"hormone":[15],"refractory":[16],"prostate":[17],"cancer":[18],"(HRPC),":[19],"but":[20],"it":[21],"also":[22,191],"survival.":[24],"We":[25,45,202],"investigated":[26],"the":[27,102],"combination":[28,171],"docetaxel":[30,51,173],"estramustine":[32,61,175],"patients":[34,78,93,146,197],"with":[35,79,186,198],"HRPC":[36,180],"regarding":[37],"efficacy":[38],"prognostic":[40,212],"parameters.":[41],"PATIENTS":[42],"AND":[43],"METHODS:":[44],"conducted":[46],"a":[47,152,193],"phase-II":[48],"trial,":[49],"administering":[50],"(70":[52],"mg/m(2)":[53],"i.v.,":[54],"day":[55,69],"2,":[56],"every":[57],"3":[58,64],"weeks)":[59],"(280":[62],"mg":[63],"times":[65],"daily":[66],"p.o.,":[67],"1":[68],"prior":[70],"to":[71,77,118],"docetaxel,":[72],"on":[73],"5":[74],"consecutive":[75],"days)":[76],"HRPC.":[80],"Patients":[81],"were":[82,94,125,163],"monitored":[83],"for":[84,196],"PSA":[85,104,138,155,204,207],"(prostate-specific":[86],"antigen)":[87],"response":[88],"toxicity.":[90,188],"RESULTS:":[91],"62":[92],"treated.":[95],"The":[96,108,115,157,170],"median":[97,103,109,116,122],"age":[98],"was":[99,105,113],"67.5":[100],"years,":[101],"177.9":[106],"ng/ml.":[107],"number":[110],"cycles":[112],"6.":[114],"time":[117,124],"progression":[119],"(TTP)":[120],"survival":[123,184,194],"14":[126],"(+/-2)":[127],"24":[129],"(+/-5)":[130],"months,":[131],"respectively.":[132],"A":[133],"=":[134,153],"50%":[135],"decrease":[136],"levels":[139],"from":[140],"baseline":[141,206],"occurred":[142],"38":[144],"(61.3%)":[145],"whom":[148],"25":[149],"(40.3%)":[150],"had":[151],"75%":[154],"decrease.":[156],"main":[158],"grade":[159],"3-4":[160],"hematologic":[161],"toxicities":[162],"neutropenia":[164],"34%":[165],"anemia":[167],"18%.":[168],"CONCLUSIONS:":[169],"exerts":[176],"substantial":[177],"activity":[178],"suggesting":[181],"an":[182],"overall":[183],"benefit":[185],"manageable":[187],"This":[189],"trial":[190],"demonstrated":[192],"advantage":[195],"early":[199],"chemotherapeutic":[200],"intervention.":[201],"identified":[203],"relapse,":[205],"hemoglobin":[209],"as":[210],"valuable":[211],"factors":[213],"this":[215],"setting.":[216]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}